Vertex Pharmaceuticals Inc / Ma (VRTX) share buybacks: $2B
Vertex Pharmaceuticals Inc / Ma spent $2B buying back its own shares in the year ended Dec 31, 2025, up 71.4% from $1.2B a year earlier.
From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · Read the filing · VRTX stock page
Vertex Pharmaceuticals Inc / Ma share buybacks by year
#111 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $2B | +71% |
| Dec 31, 2024 | $1.2B | +175% |
| Dec 31, 2023 | $428M | -70% |
| Dec 31, 2021 | $1.4B | – |
Share buybacks of similar companies
Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Eli Lilly | $4.1B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $3.4B | Dec 31, 2025 |
| Zoetis | $3.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $2B | Dec 31, 2025 |
| Royalty Pharma | $1.2B | Dec 31, 2025 |
| United Therapeutics | $1B | Dec 31, 2025 |
| AbbVie | $980M | Dec 31, 2025 |
Questions and answers
What is Vertex Pharmaceuticals Inc / Ma's share buybacks?
Vertex Pharmaceuticals Inc / Ma spent $2B buying back its own shares in the year ended Dec 31, 2025, up 71.4% from $1.2B a year earlier.
Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology